Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

ClinicalTrials.gov ID: NCT03529942

Public ClinicalTrials.gov record NCT03529942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 1:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Evaluate the Effect of the Administration of FX006 on Synovial Inflammation in Patients With Osteoarthritis of the Knee

Study identification

NCT ID
NCT03529942
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
129 participants

Conditions and interventions

Interventions

  • FX006 32 mg Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 23, 2018
Primary completion
Nov 7, 2019
Completion
Mar 8, 2020
Last update posted
Jan 23, 2024

2018 – 2020

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
TriWest Research Associates, LLC El Cajon California 92020
Biosolutions Research La Mesa California 91942
Dream Team Clinical Research (formerly located in Anaheim) Pomona California 91767
Dream Team Clinical Research Pomona California 91767
Tampa Bay Medical Research, Inc. Clearwater Florida 33761
Rush University Medical Center Chicago Illinois 60612
Duke University Medical Center Durham North Carolina 27710
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
PMG Research, Inc. d/b/a PMG Research of Knoxville Knoxville Tennessee 37938

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03529942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 23, 2024 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03529942 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →